Summary Hs578T human breast cancer cells are an oestrogen receptor (ER)-negative cell line. Treatment of these cells with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) resulted in formation of a 6.9 S nuclear aryl hydrocarbon (Ah) receptor complex, which bound to a [32P]dioxin-responsive element in a gel electrophoretic mobility shift assay. However, TCDD does not induce CYPlAl gene expression or chloramphenicol acetyl transferase (CAT) activity in cells transiently transfected with pRNHllc or pMCAT5.12, which are Ahresponsive plasmids derived from the 5'-flanking region of the human and murine CYP1A1 genes respectively. Restoration of Ah responsiveness was investigated by co-transfecting Hs578T cells with pRNH1 lc or pMCAT5.12 and plasmids that express the ER (hER), Ah receptor (AhR) and AhR nuclear translocator (Arnt) proteins. ER expression resulted in significantly increased basal CAT activity; however, TCDD did not induce CAT activity in the transiently transfected cells. Expression of the AhR or Arnt proteins did not alter basal or inducible CAT activity. Expression of N-or C-terminal truncated ER in Hs578T resulted in differential regulation of Ah responsiveness. In Hs578T cells transiently expressing the ER, which contains Cterminal deletions (amino acids 282-595), basal CAT activity was also increased; however, Ah responsiveness was not restored. In contrast, transient expression of N-terminal-deleted (amino acids 1 -178) ER resulted in a marked decrease in basal CAT activity but a restoration of Ah responsiveness. These results suggest that basal and inducible CAT activity in Hs578T cells transiently transfected with pRNHl lc is modulated differentially by ER domains that are present in the N-and C-terminal regions of the ER.
The CYPlAI gene is a member of the cytochrome P450 superfamily and expression of this gene and related enzyme activities have been extensively investigated (Nelson et al., 1993) . Inducibility of CYPlA1-dependent activities have been correlated with increased susceptibilities to lung cancer, and genetic polymorphisms in the CYPlAl gene may be associated with adenocarcinoma and squamous cell carcinoma of the lung (Kellermann et al., 1973; Anttila et al., 1991; Nakachi et al., 1993; Kelsey et al., 1994; Taioli et al., 1995) . It has also been suggested that CYPlAl-dependent aryl hydrocarbon hydroxylase (AHH) activity may be a prognostic indicator for breast cancer (Pyykk6 et al., 1991) . The induction of CYPlAl gene expression by aryl hydrocarbons (Ahs) such as 3-methylcholanthrene (MC) and 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) has been extensively investigated (reviewed in Gonzalez and Nebert, 1985; Jones et al., 1985; Fujisawa-Sehara et al., 1987; Foldes and Bresnick, 1989; Hoffman et al., 1991; Burbach et al., 1992; Ema et al., 1992; Reyes et al., 1992; Swanson and Bradfield, 1993; Whitlock, 1993; Whitelaw et al., 1993) . A number of structurally diverse compounds that bind to the intracellular Ah receptor (AhR) induce CYPlAl and the molecular biology of this response has been extensively investigated in rodents, rodent and human liver cancer cell lines in culture (Hoffman et al., 1991; Burbach et al., 1992; Ema et al., 1992; Reyes et al., 1992; Whitelaw et al., 1993) . The inducer initially binds to the intracellular AhR, which undergoes transformation to a heterodimer containing the AhR and the AhR nuclear translocator (Arnt) proteins. The nuclear AhR -Arnt complex acts as a transcription factor, which binds genomic dioxin or xenobiotic responsive elements (DREs or XREs), which are located in the 5'-flanking region of the CYPlAl and other Ah-responsive genes Jones et al., 1985 Jones et al., , 1986 Fujisawa-Sehara et al., 1987 (Foldes and Bresnick, 1989; Nemoto and Sakurai, 1991; Lusska et al., 1992; Arellano et al., 1993) . There is also evidence for the role of other trans-acting factors that can modulate induction of CYPlAI (Watson et al., 1992; Gradin et al., 1993; Reick et al., 1994; Robertson et al., 1994) , including a negative regulatory element (NRE) identified in the 5'-promoter region of the human and rat CYPlAI gene Boucher et al., 1993; Sterling et al., 1993) .
CYPlAl inducibility and polymorphisms may be an important risk factor for lung and colorectal cancers (Kellermann et al., 1973; Kawajiri and Fujiikuriyama, 1991;  Sivaraman et al., 1994) and basal CYPlA1-dependent activities in breast tumours are reported to be negative prognostic indicators for disease-free survival of women with breast cancer (Murray et al., 1991; Pyykko et al., 1991); Vickers et al., (1989) (Jaiswal et al., 1985; Ivy et al., 1988; Pasanen et al., 1988; Vickers et al., 1989; Thomsen et al., 1991 Thomsen et al., ,1994 . Moreover, several cell lines that express the AhR but are ERnegative are not Ah-responsive and these include MDA-MB-231, Hs578T and doxorubicin-resistant MCF-7 breast cancer cells (Jaiswal et al., 1985; Ivy et al., 1988; Pasanen et al., 1988; Harris et al., 1989; Vickers et al., 1989; Thomsen et al., 1991 Thomsen et al., ,1994 . A recent study from this laboratory (Thomsen et al., 1994) Transient transfection assay Cells were trypsinised, seeded in 100 mm Petri dishes with 5% FBS and phenol red-free DME/F12 medium, and grown until 70% confluent, 5-10jIg of each plasmid and 20 pg polybrene ml-' were used for each assay. After incubation for 6 h, cells were shocked using 25% dimethyl sulphoxide (DMSO) (Kawai and Nishizawa, 1984) . After 18 h, cells were treated with DMSO (0.2% total volume) or TCDD (10 nM) in DMSO for 44 h. Cells were then washed with PBS and scraped from the plates. Cell lysates were prepared in 0.16 ml of 0.25 M Tris-HCl, pH 7.5, by three freeze-thaw-sonication cycles (3 min each). Protein concentrations were determined by the Bradford method (Bradford, 1976) Gel mobility shift assay Synthetic double-stranded human DRE oligonucleotides (5'-GATCTGGCTCTTCTCACGCAACTCCG-3') (9 pmol) were labelled at the 5' end using T4 polynucleotide kinase and [y-32P]ATP (Maniatis et al., 1982; Denison and Deal, 1990 
Results
After treatment of a suspension of Hs578T cells with 10 nM [3H]TCDD for 2 h the nuclear extract was analysed by sucrose density gradient centrifugation. The results summarised in Figure 1 indicate that TCDD induces formation of a specifically bound nuclear AhR complex that is similar to that observed in other cell lines (Pasanen et al., 1988; Harris et al., 1989; Vickers et al., 1989; Thomsen et al., 1991) . The results illustrated in Figure 2 show that nuclear extracts from untreated (DMSO) cells do not form an AhR-DRE complex with retarded mobility as determined in a gel electrophoretic mobility shift assay. After treatment of the cells with 10 nM TCDD, nuclear extracts formed a specific DNA -protein band with retarded mobility, which was decreased in intensity after incubation with 100-fold excess unlabelled DRE but was essentially unchanged by co-incubation with a 100-fold excess of unlabelled mutant DRE. Thus, the nuclear AhR that forms in Hs578T cells after treatment with TCDD ( Figure 1 1.6-fold induction of CAT activity (Figure 3, lane 2) . In cells co-transfected with the hER plasmid and pRNH1lc, CAT activity in control (DMSO) cells was elevated 13.5-fold ( Figure 3 , lane 11) compared with transfection in the absence of hER. Co-transfection of hER and pRNH1Ic coupled with treatment with 10 nM TCDD also resulted in significantly increased CAT activity (Figure 3, lane 12) ; however, CAT activity was induced < 1.6-fold by TCDD. The possible restoration of Ah responsiveness in Hs578T cells was also investigated by co-transfecting cells with Arnt, AhR, Arnt plus AhR, Arnt plus AhR plus hER expression plasmids, and pRNHIlc (Table I, Figure 3 ). Co-transfection of pRNHllc with Arnt, AhR or Arnt plus AhR expression plasmids resulted in no significant changes in basal CAT activity and minimal induction by TCDD. Increased basal (but not induced) CAT activity was only observed in cells transfected with hER. A similar set of experiments was carried out using pMCAT5.12, an Ah-responsive plasmid that contains DRE2 from the murine CYPIAI gene (Table II) . TCDD did not induce CAT activity in Hs578T cells transfected with pMCAT5.12. Co-transfection of cells with pMCAT5.12 and Arnt plus AhR expression plasmids did not affect basal or inducible (TCDD) CAT activity. However, in cells treated with DMSO and co-transfected with pMCAT5.12 with the hER, hER plus Arnt, hER plus AhR or hER plus AhR plus Arnt expression plasmids resulted in a 4-to 5-fold increase in CAT activity. CAT activity was not significantly induced by TCDD in the co-transfected Hs578T cells. pRNH21c is derived from pRNH 1 lc; however, the -831 to -560 nucleotides containing the NRE sequence have been deleted . A comparison of the effects of hER on CAT activity in Hs578T cells co-transfected with pRNH Ilc or pRNH21c was also determined (Figure 4) . The results obtained with pRNH ilc were similar to those reported in Table I (Figure 4 , lanes 1, 2, 5 and 6). In contrast, CAT activity in Hs578T cells co-transfected with pRNH21c+hER was not detected in control (DMSO) cells or after treatment with TCDD.
The effects of hER and mutant hER plasmids with Cterminal deletions of amino acids 282 to 595 (HE15) or Nterminal deletions of amino acids 1-178 (HE19) on CAT activity in Hs578T cells transfected with pRNH IIc were also investigated. The results (Table III) showed that in control (DMSO) cells co-transfected with pRNHIlc plus HE15 or HE19 plasmids, there was a >2-and >47-fold decrease in CAT activity respectively, compared with cells co-transfected with pRNHI lc plus hER. In Hs578T cells co-transfected with pRNHlc plus hER, HE15 or HE19 the effects of TCDD were dependent on the expressed ER or ER fragment. The results obtained using hER (full length) or HE15 were similar and CAT activity induced by TCDD was < 1.5-fold whereas a > 23-fold induction response was observed with HE19.
Discussion
Studies in this laboratory have focused on determining the regulation of Ah responsiveness in human breast cancer cell lines using induction of CYPlAI and inhibition of oestrogeninduced gene expression as models (Harris et al., 1989; Arellano et al., 1993; Moore et al., 1993; Wang et al., 1993; Thomsen et al., 1994; Chaloupka et al., 1995) . Several reports suggest that induction of CYPlAI in human breast cancer cells by AhR agonists requires a functional ER (Jaiswal et al., 1985; Ivy et al., 1988; Pasanen et al., 1988; Harris et al., 1989; Thomsen et al., 1991 Thomsen et al., ,1994 . MDA-MB-231 cells are ER negative and Ah non-responsive; however, co-transfection of the hER plus the Ah-responsive pMCAT5.12 or pRNH1lc plasmids resulted in a significant induction of CAT activity by TCDD (Thomsen et al., 1994 Table I . DMSO-treated Hs578T cells that were transfected with pMCAT5.12 plasmid alone.
b Statistically higher (P<0.01) than DMSO-treated Hs578T cells transfected with pMCAT5.12. activity in this cell line (Arellano et al., 1993) . However, nuclear extracts from cells treated with [3H]TCDD or unlabelled TCDD form a specifically bound 6.9 S nuclear AhR complex (Figure 1 ) that binds to a [32P]DRE to give a band with retarded mobility in a gel electrophoretic mobility shift assay (Figure 2) . These results suggest that the Ah nonresponsiveness of Hs578T cells is not due to the failure of these cells to express the AhR and form a nuclear 6.9 S AhR complex or to interact with DREs. The results are in contrast to mutant benzo[a]pyrene-resistant MCF-7 breast cancer cells that also express the nuclear AhR but do not bind to a DRE (Moore et al., 1993) . The failure of the AhR to form a DRE complex is consistent with the Ah non-responsiveness of the mutant MCF-7 cells; however, the results obtained with Hs578T cells indicate that other factors must be associated with the failure to observe an induction response with TCDD. Since cycloheximide treatment of Hs578T cells also does not restore induction of CYPlAl mRNA levels by TCDD (Arellano et al., 1993) , it is unlikely that a labile protein or related factor is involved in the repressed induction response.
The effects of ER expression on Ah responsiveness in Hs578T cells were investigated by co-transfecting an hER expression plasmid with pRNH1 Ic that contains the -1142 to + 2434 sequence from the human CYPlAl gene fused to a bacterial CAT reporter gene . The results (Figure 3 and Table I) show that transient ER expression significantly increases basal CAT activity in untreated (DMSO) cells; however, induction of CAT activity by TCDD was minimal. In a series of transient transfection studies using expression plasmids for Arnt, AhR and ER or their combinations, the major response was a significant increase in basal CAT activity only in the presence of hER; in contrast, minimal induction of CAT activity by TCDD was observed. Similar results were obtained using pMCAT5.12, an Ah-responsive plasmid that contains the murine DRE2 but not the extensive 5'-regulatory DNA fragment associated with the pRNHIlc plasmid. These data are in contrast to previous transient transfection studies with MDA-MB-23 1 cells in which transient expression of ER restored Ah responsiveness with both pRNHllc and pMCAT5.12 plasmids but did not affect basal CAT activity (Thomsen et al., 1994) . Preliminary studies with MDA-MB-231 cells also show that the Arnt expression plasmid also partially restores Ah responsiveness (unpublished results) whereas this was not observed in Hs578T cells co-transfected with the Arnt expression plasmid (Tables I and II ).
An NRE has been identified in the 5'-promoter of the human CYPlAI gene (-833 pRNH21c, there was an 8.4-fold increase in basal CAT activity after deletion of the NRE and this was accompanied by a significant decrease in the fold induction of CAT activity by polynuclear aromatic hydrocarbons using pRNH21c . Based on these results from Hep G2 cells, it was hypothesised that in Hs578T cells, ER expression may derepress the effects of the NRE on the basal activity of the CYPlAl promoter. However, a comparison of basal and induced CAT activity in Hs578T cells co-transfected with hER plus pRNHl lc or pRNH21c indicates that CAT activity was minimal using the NRE-deleted pRNH21c in the presence or absence of TCDD (Figure 4 (Fuqua et al., 1993; Daffada et al., 1995; Villa et al., 1995 
